Is Alnylam Pharmaceuticals a Millionaire Maker?

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...

3I/ATLAS Threat: Harvard Expert Warns Comet Could Be 'Serial Killer'

Harvard's Avi Loeb warns that interstellar comet 3I/ATLAS could be a 'serial killer', carrying the neurotoxin hydrogen ...
Bursa

Study: COVID-19 vaccines have not increased mortality

A large epidemiological study conducted in France shows that COVID-19 vaccines have not caused an increase in overall ...

CureVac Acquisition Finalized as BioNTech Secures Controlling Stake

The prolonged uncertainty surrounding CureVac's future has concluded. BioNTech, the Mainz-based vaccine developer, has successfully cleared the final hurdle to acquire its Tübingen rival. With more ...
pharmaphorum

ASH: AstraZeneca's dual-wielding CAR-T shows promise

At this year's ASH congress, the results of the phase 1b/2 DURGA-1 of AZD0120 – a dual BCMA and CD19-directed CAR-T therapy – ...

Membrane 'neighborhood' helps transporter protein regulate cell signaling

When a cell receives a message from outside, it generates a molecule called cyclic AMP (cAMP) to relay this message. To ...
News-Medical.Net on MSN

Protein network locks ABCC4 transporters in place to maintain cyclic AMP signaling levels

When a cell receives a message from outside, it generates a molecule called cyclic AMP (cAMP) to relay this message. To ...